OpenVSafe by OpenVAERS
Search V-safe

XU6-31289-37726

2 vaccinations 7 coded responses 16 check-ins 7 free-text entries 3 call cases
Sex
Female
Age at first dose
16-20
ZIP prefix
109 / NY
Registered
2021-04-27
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-09
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-27
    Registered in v-safe
  3. 2021-04-27
    Survey response — 14 day, dose 1
    MedDRA: Abdominal pain, Diarrhoea, Medical counselling — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  4. 2021-04-27
    Report sent to call center — 14 day, dose 1
    Get care from a doctor or other healthcare professional
    1 call case(s)
  5. 2021-04-30
    Dose 2 — Pfizer-BioNTech
  6. 2021-04-30
    Health check-in — 0 day, dose 2
    Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  7. 2021-05-01
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  8. 2021-05-02
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to do your normal daily activities
    Adult check-in
  9. 2021-05-03
    Survey response — days 1–6 daily, dose 2
    MedDRA: Eye pain, Lacrimation increased — Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  10. 2021-05-04
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dizziness — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  11. 2021-05-05
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain
    Adult check-in
  12. 2021-05-06
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  13. 2021-05-07
    Health check-in — 7 day, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  14. 2021-05-14
    Survey response — 14 day, dose 2
    MedDRA: Pollakiuria — Feeling: Good
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  15. 2021-05-21
    Survey response — 21 day, dose 2
    MedDRA: Injection site pain, Pain in extremity — Feeling: Good
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  16. 2021-05-30
    Health check-in — 28 day, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-06-04
    Health check-in — 35 day, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-06-13
    Survey response — 42 day, dose 2
    MedDRA: Chromaturia, Dysmenorrhoea, Heavy menstrual bleeding, Spider vein — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  19. 2021-06-13
    Report sent to call center — 42 day, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  20. 2021-06-15
  21. 2021-10-31
    Survey response — 6 month, dose 2
    MedDRA: Arthralgia, Asthenia, Body temperature fluctuation, Diarrhoea, Fatigue, Headache, Hypersensitivity, Paraesthesia, Peripheral swelling, Syncope — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, Hospitalization
    MedDRA releases: 2024-11 · check-in answers available
  22. 2021-10-31
    Report sent to call center — 6 month, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
  23. 2021-11-03
  24. 2022-05-01
    Health check-in — 12 month, dose 2
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-04-09Pfizer-BioNTech
22021-04-30Pfizer-BioNTech

Call center

ReportedOutcomeVAERS-related outcome
2021-04-27 Unsuccessful
2021-06-13 Unsuccessful
2021-10-31 Unsuccessful

Free text

Release 8

Symptoms: Abdominal pain/diarrhea (past several days)
Healthcare visit (other): Phone consults with GI and Endocrinology doctors in recent days

Systemic reaction (other): Eye pain and watery eyes

Systemic reaction (other): Dizziness

Symptoms: Frequent urination

Symptoms: Arm pain (not at injection site) and some at injection site

Release 9

Symptoms: Severe menstrual cramping and heavier than normal menstrual cycle bleeding; spider veins on both inner thighs; neon yellow urine (now cleared)

Release 10

Symptoms: Diarrhea, headaches and head pains, joint pain, weakness, fainting, swelling of feet, tingling, temperature irregularities, fatigue, new allergic reactions, etc.

Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOMedical counselling ✓ ✓ ✓
SDAbdominal pain ✓ ✓ ✓
SDArthralgia · · ✓
SDAsthenia · · ✓
SDBody temperature fluctuation · · ✓
SDChromaturia ✓ ✓ ✓
SDDiarrhoea ✓ ✓ ✓
SDDysmenorrhoea ✓ ✓ ✓
SDFatigue · · ✓
SDHeadache · · ✓
SDHeavy menstrual bleeding ✓ ✓ ✓
SDHypersensitivity · · ✓
SDInjection site pain ✓ ✓ ✓
SDPain in extremity ✓ ✓ ✓
SDParaesthesia · · ✓
SDPeripheral swelling · · ✓
SDPollakiuria ✓ ✓ ✓
SDSpider vein ✓ ✓ ✓
SDSyncope · · ✓
SRODizziness ✓ ✓ ✓
SROEye pain ✓ ✓ ✓
SROLacrimation increased ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release